​Results from ongoing study suggest the major role of Celartics' Cov-DCVax in preventing viral infection of COVID-19 and in controlling progression of the virus-associated diseasesBeijing, May 22, 2020, Celartics Biopharma announced today the filing of a patent application covering a novel dendritic cell (DC)-based vaccine, Cov-DCVax, to fight viral infection of COVID-19. The results, led by Celar

Shenzhen, China—Among the COVID-19 coronavirus pandemic across the world, over 430,000 have been infected and nearly 300,000 have lost their lives as of May 12, according to the World Health Organization official statistics.

The Covid-19 death toll keeps surging every day. As of April 26, the coronavirus casualty has surpassed 50,000 in the United States. When there is a disaster and our beloved ones might suffer or lose life, we look up to someone competent and strong to plan, execute and lead us out of the darkness. But instead we see rivalries and blame games - pointing fingers with ridiculous reasons.

Recently, the 2019 Orthodontic Conference of Jinan University and 3rd Annual Summit Seminar (international) for the Principle and Skill on Treatment of Class III Malocclusion was held successfully by the Stomatology Departmet and The First Affiliated Hospital Of Jinan University as well as SuiHua Hospital in Guangzhou.